Literature DB >> 8818656

Narrowing the critical region for a rhabdoid tumor locus in 22q11.

J A Biegel1, C S Allen, K Kawasaki, N Shimizu, M L Budarf, C J Bell.   

Abstract

Rhabdoid tumor is a rare malignant neoplasm of childhood that may occur in various locations, including the central nervous system and the kidney. Previous cytogenetic studies of primary rhabdoid tumors have demonstrated monosomy or deletion of chromosome 22 and have implicated the presence of a rhabdoid tumor suppressor gene that maps to 22q. We have employed fluorescence in situ hybridization to narrow the region for this locus in four rhabdoid tumor cell lines with translocations or deletions involving chromosome segment 22q11. The completion of a cosmid and yeast artificial chromosome contig spanning the immunoglobulin lambda gene locus to BCR has allowed us to map a critical region for a rhabdoid tumor gene to a 500 kb span of chromosome segment 22q11.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8818656     DOI: 10.1002/(SICI)1098-2264(199606)16:2<94::AID-GCC3>3.0.CO;2-Y

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  19 in total

1.  Imaging findings in primary intracranial atypical teratoid/rhabdoid tumors.

Authors:  Hemant Parmar; Cynthia Hawkins; Eric Bouffet; James Rutka; Manohar Shroff
Journal:  Pediatr Radiol       Date:  2005-12-08

2.  Comparative mapping of the human 22q11 chromosomal region and the orthologous region in mice reveals complex changes in gene organization.

Authors:  A Puech; B Saint-Jore; B Funke; D J Gilbert; H Sirotkin; N G Copeland; N A Jenkins; R Kucherlapati; B Morrow; A I Skoultchi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

3.  A unique occurrence of a cerebral atypical teratoid/rhabdoid tumor in an infant and a spinal canal primitive neuroectodermal tumor in her father.

Authors:  Ewa Izycka-Swieszewska; Maria Debiec-Rychter; Bartosz Wasag; Agnieszka Wozniak; Dariusz Gasecki; Katarzyna Plata-Nazar; Jacek Bartkowiak; Jerzy Lasota; Janusz Limon
Journal:  J Neurooncol       Date:  2003-02       Impact factor: 4.130

4.  Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene.

Authors:  M D Taylor; N Gokgoz; I L Andrulis; T G Mainprize; J M Drake; J T Rutka
Journal:  Am J Hum Genet       Date:  2000-03-14       Impact factor: 11.025

5.  Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss.

Authors:  Mary Tsikitis; Zhikai Zhang; Winfried Edelman; David Zagzag; Ganjam V Kalpana
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-12       Impact factor: 11.205

6.  p16INK4A and p14ARF tumor suppressor pathways are deregulated in malignant rhabdoid tumors.

Authors:  Sriram Venneti; Paul Le; Daniel Martinez; Katherine W Eaton; Nikhil Shyam; Kelly L Jordan-Sciutto; Bruce Pawel; Jaclyn A Biegel; Alexander R Judkins
Journal:  J Neuropathol Exp Neurol       Date:  2011-07       Impact factor: 3.685

7.  Loss of INI1 expression defines a unique subset of pediatric undifferentiated soft tissue sarcomas.

Authors:  Portia A Kreiger; Alexander R Judkins; Pierre A Russo; Jaclyn A Biegel; Brian J Lestini; Chatchawin Assanasen; Bruce R Pawel
Journal:  Mod Pathol       Date:  2008-11-07       Impact factor: 7.842

8.  Differential expression profiling between atypical teratoid/rhabdoid and medulloblastoma tumor in vitro and in vivo using microarray analysis.

Authors:  Hsin-I Ma; Chung-Lan Kao; Yi-Yen Lee; Guang-Yuh Chiou; Lung-Kuo Tai; Kai-Hsi Lu; Chi-Shuan Huang; Yi-Wei Chen; Shih-Hwa Chiou; Ing-Chan Cheng; Tai-Tong Wong
Journal:  Childs Nerv Syst       Date:  2009-11-10       Impact factor: 1.475

9.  Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5.

Authors:  Zhi-Kai Zhang; Kelvin P Davies; Jeffrey Allen; Liang Zhu; Richard G Pestell; David Zagzag; Ganjam V Kalpana
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

10.  Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitors.

Authors:  Elizabeth M Algar; Andrea Muscat; Vinod Dagar; Christian Rickert; C W Chow; Jaclyn A Biegel; Paul G Ekert; Richard Saffery; Jeff Craig; Ricky W Johnstone; David M Ashley
Journal:  PLoS One       Date:  2009-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.